Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented DCVC Bio in the transaction. DCVC Bio announced the formation of its $400 million fund, DCVC Bio III....
DCVC Bio’s $400 Million Closing of DCVC Bio III
AIX Ventures’ $202 Million Closing of Fund II
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented AIX Ventures in the transaction. AIX Ventures announced the formation of its $202 million fund for early-stage artificial...